Status:
COMPLETED
Indirect Comparison Between Eltrombopag & Romiplostim
Lead Sponsor:
GlaxoSmithKline
Conditions:
Thrombocytopaenia
Eligibility:
All Genders
18+ years
Brief Summary
An indirect comparison to compare the efficacy of eltrombopag versus romiplostim
Detailed Description
An indirect analysis was conducted to evaluate the relative efficacy of eltrombopag and romiplostim using placebo as a common comparator
Eligibility Criteria
Inclusion
- Adults with ITP
- Pre-specified treatment
- Prospective clinical studies with at least 10 patients
Exclusion
- Adults with ITP for other reasons
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT01236014
Start Date
August 1 2009
End Date
October 1 2009
Last Update
June 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.